EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSBGRG00000005090
Gene Symbol: GUCY1A1
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSBGRG00000009963
Gene Symbol: GUCY1A2
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSBGRG00000004926
Gene Symbol: GUCY1B1
1 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSBGRG00000014769
Gene Symbol: HSP90AA1
1 Cross references
294 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSBGRG00000025141
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSBGRG00000011598
Gene Symbol: HRH2
1 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSBGRG00000022906
Gene Symbol: HRH3
1 Cross references
117 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSBGRG00000012575
Gene Symbol: HDAC1
1 Cross references
281 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSBGRG00000002796
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSBGRG00000013629
Gene Symbol: HDAC2
1 Cross references
201 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSBGRG00000025241
Gene Symbol: HDAC3
1 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSBGRG00000022459
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).